Literature DB >> 23797621

Cytokine pathways and interactions in alopecia areata.

Cerrene N Giordano1, Animesh A Sinha1.   

Abstract

Alopecia areata (AA) is an autoimmune disease resulting in the premature arrest of the follicular growth cycle clinically resulting in patchy, non-scarring hair loss. The presence of a dense follicular T cell infiltrate and variations in cytokines have led to the hypothesis that T cell activation and alterations in inflammatory mediators are crucial participants in the etiopathogenesis of the disease. Various studies suggest that the AA pathogenesis has a dominant TH1-mediated component, with potential involvement of the TH17 pathway. However, a fully integrated view of intersecting cytokine networks that support the autoimmune response in AA is lacking. A more precise understanding of cytokine pathways in disease is required to rationally explore cytokine targeted treatment strategies. Here, we comprehensively and critically review the current literature to provide a working framework regarding the complexity of T cell-cytokine interactions in AA, emphasizing the areas necessitating further research, particularly for the development of novel therapeutic options.

Entities:  

Keywords:  T-lymphocytes; alopecia; autoantigens; autoimmunity; cytokines; proinflammatory

Mesh:

Substances:

Year:  2013        PMID: 23797621     DOI: 10.1684/ejd.2013.2042

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  2 in total

1.  Serum Levels of Interleukin-2 in Patients with Alopecia Areata: Relationship with Clinical Type and Duration of the Disease.

Authors:  Emina Kasumagić-Halilovic; Semra Cavaljuga; Nermina Ovcina-Kurtovic; Lamija Zecevic
Journal:  Skin Appendage Disord       Date:  2018-02-06

Review 2.  The Role of Serum Th1, Th2, and Th17 Cytokines in Patients with Alopecia Areata: Clinical Implications.

Authors:  Anna Waśkiel-Burnat; Marta Osińska; Anna Salińska; Leszek Blicharz; Mohamad Goldust; Małgorzata Olszewska; Lidia Rudnicka
Journal:  Cells       Date:  2021-12-02       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.